Sue Wallcraft is a member of the Audit and Risk Management Committee and the Remuneration Committee. Sue is an experienced general counsel and company secretary with over 25 years’ experience in the pharmaceutical industry and health charities. She is a qualified English solicitor and brings significant legal and governance knowledge to the board. Sue is currently General Counsel and Company Secretary for Vernalis (R&D) Limited, a non-executive director of Medicines Discovery Catapult.
Susan Wallcraft
Latest news
-
First projects backed by C-Further consortium to develop better treatments for children with cancer
-
International Women’s Day 2026: Stories of support, confidence and paying it forward
-
First‑of‑its‑kind UK data initiative to boost early diagnosis and deliver better treatments for children with rare diseases